How to avoid the next nitrosamine crisis: 5 lessons learned about impurity detection

Learn more about differentiating between quality risks and data errors, and how to best ensure the quality of your products in this upcoming webinar

28 Feb 2020
Finn Price
Administrator / Office Personnel

When a crisis occurs, hindsight is a great teacher. Any company creating products that impact human health can learn from the recent nitrosamine contamination of heart drugs by looking at their own quality processes for anything that could result in a similar contamination issue. Analytical data should have been able to support confidence in the quality of manufacturing and did in fact first identify the presence of nitrosamines, but not before the contamination had spread.

In this SelectScience webinar, Heather Longden of Waters Corporation, will discuss key analytical tests, how to improve methods and gain more information about your samples and how Waters analytical expertise can help your scientists and chemists support the quality of your products, be they food, cosmetics, or drugs.

Register Now

Key learning objectives:

  • Key analytical tests that might be overlooked
  • Enhancing analytical tests to get more information about your samples
  • Improving analytical methods in regulated environments
  • Leveraging automation to minimize manual intervention and detailed review requirements
  • Using scientific review to look for quality risks rather than data errors

Who should attend?

  • Lab Managers
  • Lab Directors
  • Quality Teams
  • Quality Leaders

The live webinar takes place on Wednesday, March 11, 2020, at:

  • 16:00 GMT
  • 12:00 EDT
  • 09:00 PDT
  • 17:00 CET

Scheduling conflict? No matter, register to receive an on-demand link to watch later>>

Links

Tags